Insider Buying: Fennec Pharmaceuticals Inc. (TSE:FRX) Senior Officer Purchases 15,816 Shares of Stock

Fennec Pharmaceuticals Inc. (TSE:FRX - Get Free Report) Senior Officer Robert Christopher Andrade bought 15,816 shares of the company's stock in a transaction on Monday, November 18th. The shares were acquired at an average price of C$3.43 per share, with a total value of C$54,248.88.

Fennec Pharmaceuticals Stock Up 10.8 %

Shares of Fennec Pharmaceuticals stock traded up C$0.71 during trading hours on Friday, reaching C$7.30. 1,200 shares of the company's stock were exchanged, compared to its average volume of 1,868. The company has a current ratio of 8.02, a quick ratio of 10.17 and a debt-to-equity ratio of 1,040.68. The company has a 50 day moving average of C$6.39 and a two-hundred day moving average of C$7.98. The stock has a market cap of C$199.73 million, a P/E ratio of 65.90 and a beta of 0.25. Fennec Pharmaceuticals Inc. has a fifty-two week low of C$5.65 and a fifty-two week high of C$15.43.

Wall Street Analysts Forecast Growth

Separately, Stephens upgraded Fennec Pharmaceuticals to a "strong-buy" rating in a report on Monday.

Check Out Our Latest Analysis on FRX

About Fennec Pharmaceuticals

Fennec Pharmaceuticals Inc operates as a biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons.

See Also

• Five stocks we like better than Fennec Pharmaceuticals
• The Basics of Support and Resistance
• Tesla Investors Continue to Profit From the Trump Trade
• Stock Market Upgrades: What Are They?
• MicroStrategy’s Stock Dip vs. Coinbase’s Potential Rally
• ESG Stocks, What Investors Should Know
• Netflix Ventures Into Live Sports, Driving Stock Momentum

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].

More From MarketBeat

Amazon coin set to soar 25X – starting December 16th?

This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...

True Market Insiders | Sponsored

7 Long-Term Stocks to Own Regardless of the Election Outcome

By the time you read this, the outcome of the 2024 presidential election may (hopefully) be decided. And there...

MarketBeat

Did You See Trump’s Bombshell Exec. Order 001?

Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."

Banyan Hill Publishing | Sponsored

7 Stocks to Buy as the Travel Bubble Shows No Signs of Bursting

In 2020, travel stocks were in bad shape. Many hotels and airlines faced short-term revenue declines of up to ...

MarketBeat

$2 Trillion Disappears Because of Fed's Secretive New Move

$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...

Stansberry Research | Sponsored

7 Stocks to Buy if You Have $1,000 to Invest

A common objection that keeps people from investing is a lack of money. But the premise of that objection is t...

MarketBeat

The #1 Crypto for AI

We’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...

Weiss Ratings | Sponsored

The 12 Most-Hated Stocks on Wall Street

Wall Street research analysts must be the most optimistic people on earth. They give "buy" ratings to more tha...

MarketBeat